FDA approves Medtronic device for obsessive-compulsive disorder

02/19/2009 | MSNBC · Minneapolis/St. Paul Business Journal

Medtronic has received FDA approval for the first implant designed to treat obsessive-compulsive disorder. The Reclaim Deep Brain Stimulator, which was cleared under the "humanitarian device exemption," is a pacemaker-like device attached to four electrodes that deliver electrical jolts to brain areas that regulate mood and anxiety. The device will be made available to a small group of OCD patients who have not responded to other treatments.

View Full Article in:

MSNBC · Minneapolis/St. Paul Business Journal

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY